Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure Evidence from epidemiological observational studies

被引:5
|
作者
Zhu, Xiao-Rong [1 ]
Zhang, Yong-Peng [2 ]
Bai, Lu [3 ]
Zhang, Xue-Lian [1 ]
Zhou, Jian-Bo [1 ]
Yang, Jin-Kui [1 ,4 ]
机构
[1] Capital Med Univ, Beijing Tongren Hosp, Dept Endocrinol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Tongren Hosp, Dept Ophthalmol, Beijing, Peoples R China
[3] Beijing Haidian Hosp, Dept Geratol, Beijing, Peoples R China
[4] Beijing Key Lab Diabet Res & Care, Beijing, Peoples R China
基金
美国国家科学基金会;
关键词
all-cause mortality; diabetic retinopathy; heart failure; stroke; CARDIOVASCULAR-DISEASE; TYPE-1; DYSFUNCTION; ARTERY; COMPLICATIONS; ANGIOGENESIS; METAANALYSIS; ASSOCIATION; NIDDM; OSAKA;
D O I
10.1097/MD.0000000000005894
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To examine and quantify the potential relation between diabetic retinopathy (DR) and risk of all-cause mortality, stroke and heart failure (HF). The resources of meta-analysis of epidemiological observational studies were from Pub-med, EMBASE, CINAHL, Cochrane Library, conference, and proceedings. Random/fixed effects models were used to calculate pooled subgroup analysis stratified by different grades of DR was performed to explore the potential source of heterogeneity. Statistical manipulations were undertaken using program STATA. Of the included 25 studies, comprising 142,625 participants, 19 studies were concluded to find the relation of DR to all-cause mortality, 5 for stroke, and 3 for HF. Risk ratio (RR) for all-cause mortality with the presence of DR was 2.33 (95% CI 1.92-2.81) compared with diabetic individuals without DR. Evidences showed a higher risk of all-cause mortality associated with DR in patients with T2D or T1D (RR 2.25, 95% CI 1.91-2.65. RR 2.68, 95% CI 1.34-5.36). According to different grades of DR in patients with T2D, RR for all-cause mortality varied, the risk of nonproliferative diabetic retinopathy (NPDR) was 1.38 (1.11-1.70), while the risk of proliferative diabetic retinopathy (PDR) was 2.32 (1.75-3.06). There was no evidence of significant heterogeneity (Cochran Q test P=0.29 vs 0.26, I-2=19.6% vs 22.6%, respectively). Data from 5 studies in relation to DR and the risk of stroke showed that DR was significantly associated with increased risk of stroke (RR=1.74, 95% CI: 1.35-2.24), compared with patients without DR. Furthermore, DR (as compared with individuals without DR) was associated with a marginal increased risk of HF in patients with diabetes mellitus (DM) (n=3 studies; RR 2.24, 95% CI 0.98-5.14, P=0.056). Our results showed that DR increased the risk of all-cause mortality, regardless of the different stages, compared with the diabetic individuals without DR. DR predicted increased risk of stroke and HF. Although only 3 studies about HF were available, the association between DR and HF should be careful.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Prediction of risks of diabetic retinopathy for all-cause mortality, stroke, and heart failure: evidence from epidemiological observation
    Zhou, Jianbo
    Zhu, Xiaorong
    Zhang, Yongpeng
    Bai, Lu
    Yang, Jinkui
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 55 - 55
  • [2] Severity of Diabetic Retinopathy and the Risk of Future Cerebrovascular Disease, Cardiovascular Disease, and All-Cause Mortality
    Modjtahedi, Bobeck S.
    Wu, Jun
    Luong, Tiffany Q.
    Gandhi, Nainesh K.
    Fong, Donald S.
    Chen, Wansu
    OPHTHALMOLOGY, 2021, 128 (08) : 1169 - 1179
  • [3] Construction of a nomogram for predicting the risk of all-cause mortality in patients with diabetic retinopathy
    Zuo, Wenwei
    Yang, Xuelian
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [4] Frailty and the risk of all-cause mortality and hospitalization in chronic heart failure: a meta-analysis
    Uchmanowicz, Izabella
    Lee, Christopher S.
    Vitale, Cristiana
    Manulik, Stanislaw
    Denfeld, Quin E.
    Uchmanowicz, Bartosz
    Rosinczuk, Joanna
    Drozd, Marcin
    Jaroch, Joanna
    Jankowska, Ewa A.
    ESC HEART FAILURE, 2020, 7 (06): : 3427 - 3437
  • [5] Depression after heart failure and risk of cardiovascular and all-cause mortality: A meta-analysis
    Fan, Hongjie
    Yu, Weidong
    Zhang, Qiang
    Cao, Hui
    Li, Jun
    Wang, Junpeng
    Shao, Yang
    Hu, Xinhua
    PREVENTIVE MEDICINE, 2014, 63 : 36 - 42
  • [6] Prediction of all-cause mortality with hypoalbuminemia in patients with heart failure: a meta-analysis
    Peng, Wenhua
    Zhang, Channa
    Wang, Zhijun
    Yang, Wenqi
    BIOMARKERS, 2019, 24 (07) : 631 - 637
  • [7] Quality of life and the associated risk of all-cause mortality in nonischemic heart failure
    Bundgaard, Johan S.
    Thune, Jens J.
    Gislason, Gunnar
    Fosbol, Emil L.
    Torp-Pedersen, Christian
    Aagaard, David
    Nielsen, Jens C.
    Haarbo, Jens
    Thogersen, Anna M.
    Videbaek, Lars
    Jensen, Gunnar
    Olesen, Line L.
    Kristensen, Soren L.
    Pedersen, Susanne S.
    Kober, Lars
    Mogensen, Ulrik M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 305 : 92 - 98
  • [8] Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study
    Kabootari, Maryam
    Raee, Mohammad Reza
    Akbarpour, Samaneh
    Asgari, Samaneh
    Azizi, Fereidoun
    Hadaegh, Farzad
    BMJ OPEN, 2018, 8 (11):
  • [9] Depression and markers of inflammation as predictors of all-cause mortality in heart failure
    Mommersteeg, Paula M. C.
    Schoemaker, Regien G.
    Naude, Petrus J. W.
    Eisel, Ulrich L. M.
    Garrelds, Ingrid M.
    Schalkwijk, Casper G.
    Westerhuis, Bert W. J. J. M.
    Kop, Willem J.
    Denollet, Johan
    BRAIN BEHAVIOR AND IMMUNITY, 2016, 57 : 144 - 150
  • [10] Obstructive sleep apnoea and risks of all-cause mortality: preliminary evidence from prospective cohort studies
    Pan, Lei
    Xie, Xiaomei
    Liu, Dayue
    Ren, Dunqiang
    Guo, Yongzhong
    SLEEP AND BREATHING, 2016, 20 (01) : 345 - 353